Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis

NCT06584045 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06584045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06584045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2024
Completion date
December 31, 2029
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis, autoimmune encephalitis caused by n-methyl d-aspartate receptor antibody, encephalitis, encephalitis, viral